1. Home
  2. LIF vs ALKS Comparison

LIF vs ALKS Comparison

Compare LIF & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life360 Inc.

LIF

Life360 Inc.

HOLD

Current Price

$56.96

Market Cap

4.9B

Sector

N/A

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$31.66

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIF
ALKS
Founded
2008
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
LIF
ALKS
Price
$56.96
$31.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$91.93
$42.85
AVG Volume (30 Days)
803.8K
1.8M
Earning Date
02-26-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.44
EPS
0.12
2.02
Revenue
$459,031,000.00
$1,521,338,000.00
Revenue This Year
$30.95
N/A
Revenue Next Year
$31.65
$22.50
P/E Ratio
$157.55
$15.72
Revenue Growth
33.86
1.08
52 Week Low
$29.62
$25.17
52 Week High
$112.54
$36.45

Technical Indicators

Market Signals
Indicator
LIF
ALKS
Relative Strength Index (RSI) 27.37 70.93
Support Level $61.05 $28.93
Resistance Level $66.30 $31.96
Average True Range (ATR) 2.33 0.94
MACD -0.20 0.38
Stochastic Oscillator 0.79 94.17

Price Performance

Historical Comparison
LIF
ALKS

About LIF Life360 Inc.

Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: